Search Results 2391-2400 of 16637 for STD Testing Stigma

1. Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma - Mayo Clinic

   Monoclonal antibody-drug conjugates, such as brentuximab vedotin, can block cancer growth in different ways by targeting certain cells. Crizotinib and ...

2. Radiotherapy To Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer - Mayo Clinic

   This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the ...

3. A Study Of Signia™ Circular Stapler With Tri-Staple For Left-sided Colon, Sigmoid, And Rectal Resections - Mayo Clinic

   Specifically, the primary objective is to evaluate if the incidence of anastomotic leak within 30 days is below the performance goal set at 9.3%. Participation ...

4. Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer - Mayo Clinic

   About this study. This randomized phase II/III trial studies how well paclitaxel, carboplatin, and metformin hydrochloride works and compares it to ...

5. The BROADEN Study: A Study Of Volanesorsen (Formerly ISIS-APOCIIIRx) In Patients With Familial Partial Lipodystrophy - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and safety of volanesorsen (IONIS-APOCIIIRx) given for 52 weeks in patients with Familial Partial ...

6. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma

   A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma.

8. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

   Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

9. Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma - Mayo Clinic

   About this study. This phase II trial studies how well glembatumumab vedotin works in treating patients with middle layer of the wall of the eye (uveal) ...

10. Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer - Mayo Clinic

    Collecting information over time about how often lymphedema occurs in patients undergoing surgery and lymphadenectomy for endometrial cancer, cervical cancer, ...